POLARIS for Preclinical Research
Metabolic Imaging Research
Pre-clinicalActive
Key Facts
About NVision Imaging
NVision Imaging is pioneering metabolic magnetic resonance imaging (MRI) by commercializing a quantum-based hyperpolarization technology called POLARIS. This technology enhances the MRI signal of natural metabolic agents by over 10,000x, allowing existing MRI scanners to visualize cellular-level metabolic activity in near real-time. The primary application is the early differentiation of resistant versus sensitive tumors within days of starting cancer therapy, enabling adaptive treatment strategies. The company's platform also has potential applications across cardiology, hepatology, neurology, and other therapeutic areas.
View full company profile